Literature DB >> 1324638

In vitro activity of temafloxacin compared with those of other agents against 100 clinical isolates of Neisseria gonorrhoeae.

A E Glatt1, M Cummings, W McCormack.   

Abstract

The activity of temafloxacin hydrochloride was evaluated by agar dilution against 100 clinical isolates of Neisseria gonorrhoeae and compared with the activities of penicillin, tetracycline, ceftriaxone, ciprofloxacin, and ofloxacin. Temafloxacin inhibited 100% of study isolates at a concentration of 0.015 microgram/ml or less and was highly active against penicillin- and tetracycline-resistant strains. The in vitro activity of temafloxacin was nearly identical to that of ceftriaxone and was slightly less than that observed with ciprofloxacin and ofloxacin. Temafloxacin represents a promising alternative agent for investigation in the treatment of infection due to N. gonorrhoeae.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324638      PMCID: PMC188849          DOI: 10.1128/AAC.36.5.1131

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing strains.

Authors:  J M Covino; M Cummings; B Smith; S Benes; K Draft; W M McCormack
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

2.  National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project.

Authors:  S K Schwarcz; J M Zenilman; D Schnell; J S Knapp; E W Hook; S Thompson; F N Judson; K K Holmes
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

3.  Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia.

Authors:  J P Bryan; S K Hira; W Brady; N Luo; C Mwale; G Mpoko; R Krieg; E Siwiwaliondo; C Reichart; C Waters
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.

Authors:  J Segreti; D J Hirsch; A A Harris; K S Kapell; H Orbach; H A Kessler
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 5.  Therapy for gonococcal infections: options in 1989.

Authors:  J S Moran; J M Zenilman
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

6.  Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.

Authors:  R N Jones; T L Gavan; C Thornsberry; P C Fuchs; E H Gerlach; J S Knapp; P Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.

Authors:  K Nye; Y G Shi; J M Andrews; J P Ashby; R Wise
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

8.  Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea.

Authors:  K M Pabst; N A Siegel; S Smith; J R Black; H H Handsfield; E W Hook
Journal:  Sex Transm Dis       Date:  1989 Jul-Sep       Impact factor: 2.830

9.  Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.

Authors:  D J Hardy; R N Swanson; D M Hensey; N R Ramer; R R Bower; C W Hanson; D T Chu; P B Fernandes
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

10.  In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.

Authors:  A L Barry; R N Jones
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.